crystal structure of PDE4D catalytic domain and zardaverine complex homo-6-mer 388-715
99.69 6×ZN; 6×MG; 6×ZAR; PDE4 complexed with inhibitor homo-4-mer 387-738
100.0 4×3KQ; 4×ZN; 4×MG; Crystal structure of PDE4D2 in complex with inhibitor LEO39652 homo-4-mer 381-714
100 4×QDT; 28×EDO; 4×DMS; 4×MG; 4×ZN; Crystal structure of PDE4D2 in complex with (R,S)-rolipram homo-4-mer 381-714
100 8×ZN; 4×ROL; Crystal structure of PDE4D in complex with L-869298 homo-4-mer 381-714
100 4×ZN; 4×MG; 4×M98; Crystal structure of PDE4D2 in complex with inhibitor L-869299 homo-4-mer 381-714
100 4×ZN; 4×MG; 4×M99; Structure of PDE4D2-IBMX homo-4-mer 381-714
100 4×ZN; 4×MG; 4×IBM; Three dimensional structures of PDE4D in complex with roliprams and implication on inhibitor select… homo-4-mer 381-714
100 8×ZN; 4×ROL; The Crystal Structure of AMP-Bound PDE4 Suggests a Mechanism for Phosphodiesterase Catalysis homo-4-mer 381-714
100 8×ZN; 4×AMP; Crystal structure of the PDE4D catalytic domain in complex with GEBR-42a homo-2-mer 382-714
100 2×ZN; 8×MG; 28×EDO; 2×T3K; Crystal structure of the PDE4D catalytic domain in complex with GEBR-41b homo-2-mer 382-714
100 2×S8Q; 2×ZN; 8×MG; 14×EDO; Crystal structure of the PDE4D catalytic domain in complex with GEBR-18a homo-2-mer 383-714
100 2×ZN; 5×MG; 2×D0E; Crystal structure of the PDE4D catalytic domain in complex with GEBR-32a homo-2-mer 385-714
100 2×ZN; 5×MG; 2×EDO; 1×DD5; 1×D5N; Crystal structure of the PDE4D catalytic domain in complex with GEBR-4a homo-2-mer 386-714
100 2×ZN; 5×MG; 2×CZT; Crystal structure of the PDE4D catalytic domain in complex with GEBR-7b homo-2-mer 386-714
100 3×MG; 2×ZN; 2×CV8; 2×GOL; Crystal structure of the PDE4D catalytic domain in complex with GEBR-18b homo-2-mer 387-714
100 2×ZN; 4×MG; 2×D0B; Crystal structure of PDE4D catalytic domain in complex with arctigenin homo-2-mer 388-714
100 2×ZN; 2×MG; 2×EQC; 26×EDO; Structure of the PDE4D-cAMP complex homo-2-mer 388-714
99.69 2×ZN; 2×CMP; Crystal structure of PDE4D2 in complex with inhibitor NPV homo-2-mer 388-714
100 2×NPV; 2×ZN; 2×MG; Crystal structure of PDE4D catalytic domain in complex with Apremilast homo-2-mer 388-714
100 3×MG; 2×ZN; 11×EDO; 2×A9L; The structure of the catalytic domain of human PDE4d with 4-(3-Butoxy-4-methoxyphenyl)methyl-2-imid… homo-2-mer 388-714
100 2×ZN; 2×0MO; 2×MG; Crystal structure of PDE4D catalytic domain complexed with compound 21d homo-2-mer 388-714
100 2×ZN; 2×MG; 2×AQL; Crystal structure of PDE4D catalytic domain in complex with compound 36 homo-2-mer 388-713
100 2×ZN; 2×MG; 2×FTX; 12×EDO; Crystal structure of PDE4D complexed with benzbromarone homo-2-mer 388-713
100 2×ZN; 2×MG; 2×R75; 2×EDO; Crystal structure of PDE4D complexed with ethaverine hydrochloride homo-2-mer 388-713
100 2×VIC; 2×MG; 2×ZN; 1×EDO; The crystal structure of PDE4D with Amentoflavone homo-2-mer 388-713
100 2×ZN; 2×MG; 2×A1D6Q; Crystal structure of PDE4D complexed with a novel inhibitor homo-2-mer 389-713
100 3×MG; 2×ZN; 2×AH6; 11×EDO; Crystal structure of PDE4D complexed with a novel inhibitor homo-2-mer 389-713
100 2×ZN; 4×MG; 2×AH9; 11×EDO; Crystal structure of PDE4D complexed with a novel inhibitor homo-2-mer 389-713
100 2×ZN; 2×MG; 2×AJX; 14×EDO; Crystal structure of PDE4D complexed with a novel inhibitor homo-2-mer 389-713
100 2×ZN; 4×MG; 2×AH3; 13×EDO; Crystal structure of PDE4D complexed with a novel inhibitor homo-2-mer 389-713
100 2×AKO; 3×MG; 2×ZN; 5×EDO; PDE4D complexed with inhibitor homo-2-mer 389-713
100.0 2×3GJ; 4×ZN; The crystal structure of PDE4D with isoaurostatin derivatives 1-12 homo-2-mer 389-713
100 2×ZN; 2×MG; 2×A1D8N; Crystal structure of PDE4D complexed with a novel inhibitor homo-2-mer 390-713
100 2×ZN; 2×MG; 10×EDO; 2×AK0; Crystal structure of PDE4D complexed with a novel inhibitor homo-2-mer 390-713
100 2×ZN; 4×MG; 2×AH9; 15×EDO; Crystal structure of PDE4D complexed with 7b-1 homo-2-mer 390-713
100 2×MG; 2×ZN; 2×W8E; 4×EDO; Crystal structure of PDE4D complexed with a novel inhibitor homo-2-mer 390-713
100 2×ZN; 3×MG; 2×AJL; 12×EDO; Crystal structure of PDE4D complexed with CX-4945 homo-2-mer 390-713
100 2×MG; 2×ZN; 2×3NG; 6×EDO; Crystal structure of PDE4D complexed with DCN homo-2-mer 390-713
100 2×MG; 2×ZN; 2×W8O; 3×EDO; Crystal structure of PDE4D complexed with a novel inhibitor homo-2-mer 390-713
100 2×ZN; 2×MG; 2×AKU; 4×EDO; Crystal structure of the PDE4D catalytic domain in complex with GEBR-26g homo-2-mer 392-715
100 2×ZN; 4×MG; 2×D08; 2×EDO; 1×DMS; PDE4D crystal structure in complex with small molecule inhibitor homo-2-mer 390-713
100.0 2×ZN; 2×MG; 2×6Q2; 32×EDO; Crystal structure of PDE4D complexed with a novel inhibitor homo-2-mer 390-713
100 2×ZN; 2×MG; 2×AKU; 1×EDO; The crystal structure of PDE4D with isoaurostatin derivatives 2-6 homo-2-mer 389-712
100 2×ZN; 2×MG; 2×A1D8P; The crystal structure of PDE4D with isoaurostatin derivatives 2-1 homo-2-mer 389-712
100 2×ZN; 2×MG; 2×A1D8O; Crystal structure of human phosphodiesterase 4d (PDE4d) with papaverine. homo-2-mer 388-711
100 2×ZN; 2×MG; 2×EV1; Crystal structure of PDE4D complexed with CVT-313 homo-2-mer 390-712
100 2×AJR; 2×MG; 2×ZN; 8×EDO; Crystal structure of PDE4D complexed with glycyrrhisoflavone homo-2-mer 390-712
100 2×ZN; 2×MG; 2×JN0; 5×EDO; Crystal structure of PDE4D complexed with licoisoflavone A homo-2-mer 390-712
100 2×ZN; 2×MG; 2×JU3; 5×EDO; Crystal structure of the PDE4D catalytic domain in complex with GEBR-54 homo-2-mer 392-714
100 2×CZK; 4×MG; 2×ZN; 1×EDO; Crystal structure of PDE4D catalytic domain complexed with compound 22d homo-2-mer 390-712
100 2×ZN; 2×MG; 2×AWI; Crystal structure of the PDE4D catalytic domain in complex with GEBR-20b homo-2-mer 392-714
100 2×ZN; 5×MG; 3×CZQ; Crystal structure of PDE4D catalytic domain complexed with compound 23a homo-2-mer 390-712
100 2×ZN; 2×MG; 2×B6V; The crystal structure of PDE4D with isoaurostatin derivatives 2-9 homo-2-mer 392-713
100 2×ZN; 2×MG; 2×A1D8Q; Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-48 monomer 326-718
100.0 1×ZN; 2×MG; 1×KRD; Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN14770 monomer 326-718
100.0 2×ZN; 1×MG; 1×KR7; 1×BTB; 1×SO4; 1×EDO; Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-49 monomer 326-718
100.0 1×ZN; 1×MG; 1×KR4; Crystal structure of human phosphodiesterase 4D with bound allosteric modulator monomer 326-714
100.0 1×15X; 1×ZN; 1×MG; 1×EPE; Crystal structure of human phosphodiesterase 4d with regulatory domain and d155871 monomer 327-714
100.0 1×ZN; 1×MG; 1×CA; 1×D71; Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN5004 monomer 390-734
100.0 2×ZN; 1×MG; 1×E31; 1×CL; Crystal structure of human phosphodiesterase 4d with d155988/pmnpq monomer 380-714
100 1×ZN; 1×MG; 1×SO4; 1×988; 4×EDO; Crystal structure of PDE4D catalytic domain complexed with Selaginpulvilins K monomer 381-714
100 1×J20; 1×ZN; 1×MG; Crystal structure of human phosphodiesterase 4d with d155871 monomer 384-714
100 1×ZN; 1×MG; 1×SO4; 1×D71; 3×EOH; Crystal structure of the catalytic domain of PDE4D2 with (S)-N-(3-{1-[1-(3-Cyclopropylmethoxy-4-dif… monomer 384-714
100 1×IHM; 2×ZN; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-048 monomer 383-713
100 1×ZN; 1×MG; 13×EDO; 1×EPE; 1×E6Z; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-617 monomer 384-713
100 1×ZN; 2×MG; 1×QWT; 15×EDO; 1×PEG; 5×DMS; 1×EPE; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-769 monomer 384-713
100 1×ZN; 1×MG; 19×EDO; 1×J2E; 1×EPE; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-226 monomer 384-713
100 1×ZN; 1×MG; 21×EDO; 1×PEG; 1×D5T; Crystal structure of human phosphodiesterase 4d with rolipram monomer 384-713
100 1×ZN; 1×MG; 1×SO4; 1×ROL; 8×EDO; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-356 monomer 384-713
100 1×ZN; 1×MG; 15×EDO; 6×PEG; 1×D62; 1×EPE; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-656 monomer 384-713
100 1×ZN; 1×MG; 10×EDO; 1×QWZ; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-001 monomer 384-713
100 1×ZN; 1×MG; 8×EDO; 2×DTT; 1×6M5; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-768 monomer 384-713
100 1×ZN; 1×MG; 7×EDO; 1×EPE; 1×RLW; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-007 monomer 385-713
100 1×ZN; 1×MG; 20×EDO; 1×PEG; 1×EPE; 1×E8H; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1439 monomer 385-713
100 1×ZN; 1×MG; 19×EDO; 1×PEG; 1×D68; 1×EPE; 1×NI; Crystal structure of the catalytic domain of PDE4D2 with compound 10D monomer 385-713
100 2×ZN; 16×EDO; 2×DMS; 1×PEG; 1×PO4; 1×JN4; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-637 monomer 385-713
100 1×ZN; 1×MG; 10×EDO; 1×E3Q; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-053 monomer 385-713
100 1×ZN; 1×MG; 12×EDO; 1×PEG; 1×DTT; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-425 monomer 385-713
100 1×ZN; 1×MG; 9×EDO; 1×E6E; 1×EPE; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1361 monomer 385-713
100 1×ZN; 1×MG; 13×EDO; 1×DMS; 1×863; 1×EPE; CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH A TETRAFLUORANLINE COMPOUND monomer 386-714
100.0 1×ZN; 1×MG; 1×SO4; 3×EOH; 1×7DJ; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-635 monomer 385-713
100 1×ZN; 1×MG; 9×EDO; 1×EPE; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-654 monomer 385-713
100 1×ZN; 1×MG; 9×EDO; 1×EPE; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-417 monomer 385-713
100 1×ZN; 1×MG; 9×EDO; 1×EPE; 1×4I7; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-3098 monomer 385-713
100 1×ZN; 1×MG; 7×EDO; 1×E6N; 1×EPE; Crystal structure of human phosphodiesterase 4d with roflumilast monomer 385-713
100.0 1×ZN; 1×MG; 1×SO4; 1×ROF; 3×EDO; Crystal structure of the catalytic domain of PDE4D2 with compound 2 monomer 385-712
100 1×2SR; 8×EDO; 1×PEG; 2×ZN; 2×DMS; Crystal structure of the catalytic domain of PDE4D2 complexed with compound 10d monomer 385-712
100 2×ZN; 1×J25; 2×EDO; 1×DMS; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1335 monomer 385-711
100 15×EDO; 2×PEG; 1×ZN; 1×FFZ; 1×MG; 1×EPE; Crystal structure of the apo form of the catalytic domain of PDE4D2 monomer 385-711
100 17×EDO; 1×PEG; 2×ZN; 1×PO4; Crystal structure of PDE4D catalytic domain complexed with compound 1 monomer 387-713
100 1×ZN; 1×MG; 1×A1L61; Crystal structure of the catalytic domain of PDE4D2 with compound 12c monomer 386-712
100 2×ZN; 9×EDO; 1×JN8; Crystal structure of the catalytic domain of PDE4D2 with compound 10o monomer 386-712
100 13×EDO; 2×ZN; 1×PEG; 1×JN7; Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1-(3-nitro-phenyl)-1H-p… monomer 388-713
100 1×ZN; 1×MG; 1×7DE; 18×EDO; Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1H-pyrazole-4-carboxyli… monomer 388-713
100 1×ZN; 1×MG; 1×DEE; 11×EDO; Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Cilomilast monomer 388-713
100 1×ZN; 1×MG; 1×CIO; 9×EDO; Crystal structure of PDE4D2 in complex with inhibitor (S_Zl-n-91) monomer 388-713
100 1×AKJ; 1×ZN; 2×MG; Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1-phenyl-1H-pyrazole-4-… monomer 388-713
100 1×ZN; 1×MG; 1×3DE; 10×EDO; Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 1-(4-methoxy-phenyl)-3,5-dimethyl-1H… monomer 388-713
100 1×ZN; 1×MG; 1×4DE; 12×EDO; Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Piclamilast monomer 388-713
100.0 1×ZN; 1×MG; 1×PIL; 1×B3P; 20×EDO; Crystal structure of the PDE4D2 catalytic domain in complex with inhibitor (R)-Zl-n-91 monomer 388-713
100 1×R91; 1×ZN; 2×MG; Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Roflumilast monomer 388-713
100 1×ZN; 1×MG; 12×EDO; 1×ROF; Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 1-(4-amino-phenyl)-3,5-dimethyl-1H-p… monomer 388-713
100 1×ZN; 1×MG; 1×5DE; 8×EDO; Catalytic Domain Of Human Phosphodiesterase 4D In Complex With AMP monomer 389-713
100.0 1×ZN; 1×MG; 1×AMP; 14×EDO; 1×B3P; Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1086 monomer 390-714
100 11×EDO; 2×D5Z; 1×MG; 1×ZN; 1×EPE; Crystal structure of PDE4D catalytic domain complexed with compound 18d monomer 388-712
100 1×ZN; 1×MG; 1×1GF; Crystal structure of the PDE4D catalytic domain in complex with osthole monomer 390-714
100 2×ZN; 1×A0O; PDE4 crystal structure in complex with small molecule inhibitor monomer 389-713
100.0 1×6PT; 1×ZN; 1×MG; Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Zardaverine monomer 390-713
100.0 1×ZN; 1×MG; 1×ZAR; Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Rolipram monomer 390-713
100.0 1×ZN; 1×MG; 1×ROL; 5×EDO; Crystal structure of PDE4D catalytic domain complexed with 33a monomer 390-713
100 1×ZN; 1×MG; 1×8GO; The crystal structure of PDE4D with 2317b monomer 390-713
100 1×ZN; 1×MG; 1×A1EKX; Crystal structure of PDE4D catalytic domain complexed with 17 monomer 390-713
100 1×ZN; 1×MG; 1×8G7; Crystal structure of PDE4D catalytic domain complexed with compound 4e monomer 390-712
100 1×M36; 1×ZN; 1×MG; Crystal structure of PDE4D catalytic domain complexed with L11 monomer 392-713
100 1×A1D5M; 1×ZN; 1×MG; Crystal structure of PDE4D catalytic domain complexed with compound 17a monomer 390-711
100 1×ZN; 1×MG; 1×0X8; Crystal structure of PDE4D catalytic domain complexed with compound 18a monomer 393-712
100 1×ZN; 1×MG; 1×1AS; The structure of the RACK1 interaction sites located within the unique N-terminal region of the cAM… monomer 250-280
29.03